Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003949 |
---|---|
Receipt number | R000004739 |
Scientific Title | A phase II study of Bevacizumab combined with Carboplatin and Weekly Paclitaxel for Patients with Advanced Non-Squamous Non-Small-Cell Lung Cancer. North Japan Lung Cancer Study Group Trial 1002 |
Date of disclosure of the study information | 2010/07/31 |
Last modified on | 2011/03/31 13:04:47 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/07/26 18:15:10 | ||
2 | Update | 2010/08/02 15:42:06 | Recruitment status |
|
3 | Update | 2010/08/12 11:41:23 | Public title |
|
4 | Update | 2010/08/12 11:42:03 | Narrative objectives1 |
|
5 | Update | 2010/08/12 11:44:16 | Interventions/Control_1 |
|
6 | Update | 2010/08/13 12:51:24 | Public title |
|
7 | Update | 2010/08/13 12:52:27 | Org. issuing International ID_1 |
|
8 | Update | 2011/01/27 20:16:16 | Key inclusion criteria Key inclusion criteria |
|
9 | Update | 2011/01/28 20:35:53 | Key inclusion criteria |
|
10 | Update | 2011/03/17 14:22:40 | Recruitment status |
|
11 | Update | 2011/03/31 13:04:47 | Email Email1 |